Metformin: the updated protective property in kidney disease

Metformin is a frontline hypoglycemic agent, which is mainly prescribed to manage type 2 diabetes mellitus with obesity. Emerging evidence suggests that metformin also exerts protective effects against various kidney diseases. Some postulate that kidney disease is actually a metabolic disease, accom...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qingjun, Lu, Xing, Zhao, Chunfei, Liao, Shuzhen, Chen, Xiaoqun, Guo, Fengbiao, Yang, Chen, Liu, Hua-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244070/
https://www.ncbi.nlm.nih.gov/pubmed/32364526
http://dx.doi.org/10.18632/aging.103095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244070/
https://www.ncbi.nlm.nih.gov/pubmed/32364526
http://dx.doi.org/10.18632/aging.103095

Ejemplares similares